The impact of long-term warfarin on the quality of life of elderly people with atrial fibrillation [1]

Age and Ageing

Volumn 36, Issue 1, 2007, Pages 95-97

  Das, Abhay K ^a   Willcoxson, Paul D ^a   Corrado, Oliver J ^a   West, Robert M ^b  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

WARFARIN; ANTICOAGULANT AGENT;

AGED; ANTICOAGULANT THERAPY; CONTROLLED STUDY; DATA ANALYSIS; DRUG USE; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; LETTER; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PRESCRIPTION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; STATISTICAL ANALYSIS; THROMBOSIS PREVENTION; TREATMENT DURATION; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; STATISTICAL MODEL;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; CEREBROVASCULAR ACCIDENT; CROSS-SECTIONAL STUDIES; HUMANS; LINEAR MODELS; QUALITY OF LIFE; WARFARIN;

EID: 33947589523     PISSN: 00020729     EISSN: 14682834     Source Type: Journal    
DOI: 10.1093/ageing/afl062     Document Type: Letter

References (16)

1. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation. Arch Intern Med 1995; 155: 469-73.
2. Ho SF, O'Mahony MS, Steward JA, Burr ML, Buchalter M. Left ventricular systolic dysfunction and atrial fibrillation in older people in the community - a need for screening? Age Ageing 2004; 33: 488-92.
3. Wattigney WA, Mensah GA, Croft JB. Increasing trends in hospitalisation for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention. Circulation 2003; 108: 711-16.
4. Hart RG, Benavente O, McBride R, Pearce LA. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: A meta-analysis. Ann Intern Med 1999; 131: 492-501.
5. Gage BF, Waterman AD, Shannon W et al. Validation of clinical classification schemes for predicting stroke. Results from the national registry of atrial fibrillation. JAMA 2001; 285: 2864-70.
6. Wheeldon NM, Taylor DI, Anagnostou E, Cook D, Wales C, Oakley GDG. Screening for atrial fibrillation in primary care. Heart 1998; 79: 50-5.
7. Hart RG, Halperin JL. Atrial fibrillation and thromboembolism: A decade of progressive stroke prevention. Ann Intern Med 1999; 131: 688-95.
8. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) investigators. A comparison of the rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002; 347: 1834-40.
9. Sudlow M, Thomson R, Thwaites B, Rodgers H, Kenny RA. Prevalence of atrial fibrillation and eligibility for anticoagulants in the community. Lancet 1998; 352: 1167-71.
10. McCrory DC, Matchar DB, Samsa G, Sanders LL, Pritchett ELC. Physician attitude s about anticoagulation for non-valvular atrial fibrillation in the elderly. Arch Intern Med 1995; 155: 277-81.
11. Devereaux PJ, Anderson DR, Gardner MJ et al. Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: Observational study. BMJ 2001; 323: 1218-22.
12. Dorian P, Paquette M, Newman D, Green MS, Talajic M, Roy D. Quality of life improves following treatment in Canadian Trial of Atrial Fibrillation. Circulation (Suppl 1) 1999; 100: 1-502.
13. Ware JE, Sherbourne CD. The MOS 36-item short form health survey. Conceptual framework and item selection. Med Care 1992; 30: 473-81.
14. Hayes V, Morris J, Wolfe C et al. The SF-36 Health Survey Questionnaire: Is it suitable for use with older adults? Age Ageing 1995; 24: 120-5.
15. Kirkwood BR. Essentials of Medical Statistics. Blackwell Science, 1988; 199.
16. Lancaster TR, Singer DE, Sheehan MA et al. The impact of long-term warfarin therapy on quality of life - the Boston Area Anticoagulation Trial for Atrial Fibrillation Investigation. Arch Intern Med 1991; 15: 1944-9.